US 11,840,577 B2
Antigen binding proteins specifically binding MAGE-A
Meike Hutt, Stuttgart (DE); Felix Unverdorben, Stuttgart (DE); Sebastian Bunk, Tuebingen (DE); Dominik Maurer, Moessingen (DE); Martin Hofmann, Tuebingen (DE); Gabriele Pszolla, Tuebingen (DE); Sara Yousef, Tuebingen (DE); Claudia Wagner, Tuebingen (DE); Frank Schwoebel, Berlin (DE); and Heiko Schuster, Tuebingen (DE)
Assigned to IMMATICS BIOTECHNOLOGIES GMBH, Tuebingen (DE)
Filed by Immatics Biotechnologies GmbH, Tuebingen (DE)
Filed on Jul. 30, 2020, as Appl. No. 16/943,779.
Claims priority of provisional application 62/905,782, filed on Sep. 25, 2019.
Claims priority of provisional application 62/882,131, filed on Aug. 2, 2019.
Claims priority of application No. 10 2019 121 007.0 (DE), filed on Aug. 2, 2019.
Prior Publication US 2021/0032361 A1, Feb. 4, 2021
Int. Cl. C07K 16/30 (2006.01); C07K 16/46 (2006.01); C07K 14/725 (2006.01); A61P 35/00 (2006.01)
CPC C07K 16/30 (2013.01) [A61P 35/00 (2018.01); C07K 14/7051 (2013.01); C07K 2317/24 (2013.01); C07K 2317/32 (2013.01); C07K 2317/55 (2013.01); C07K 2317/565 (2013.01); C07K 2317/567 (2013.01); C07K 2317/622 (2013.01); C07K 2317/92 (2013.01)] 9 Claims
 
1. A protein comprising a first polypeptide and a second polypeptide, wherein
the first polypeptide comprises the amino acid sequence of SEQ ID NO: 136, and
the second polypeptide comprises the amino acid sequence of SEQ ID NO: 137.